Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines

被引:17
作者
Graner, Michael W. [1 ]
Lillehei, Kevin O. [1 ]
Katsanis, Emmanuel [2 ]
机构
[1] Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO 80045 USA
[2] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA
关键词
endoplasmic reticulum; cancer vaccine; chaperones; CRCL; immunotherapy; HEAT-SHOCK PROTEINS; MHC CLASS-I; CELL-SURFACE CALRETICULIN; NATURAL-KILLER-CELLS; CROSS-PRESENTATION; IMMUNE-RESPONSE; HEAT-SHOCK-PROTEIN-70; HSP70; DISULFIDE-ISOMERASE; ENDOGENOUS LIGANDS; ENDOTHELIAL CELLS;
D O I
10.3389/fonc.2014.00379
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The endoplasmic reticulum (ER) is a major site of passage for proteins en route to other organelles, to the cell surface, and to the extracellular space. It is also the transport route for peptides generated in the cytosol by the proteasome into the ER for loading onto major histocompatibility complex class I (MHC I) molecules for eventual antigen presentation at the cell surface. Chaperones within the ER are critical for many of these processes; however, outside the ER certain of those chaperones may play important and direct roles in immune responses. In some cases, particular ER chaperones have been utilized as vaccines against tumors or infectious disease pathogens when purified from tumor tissue or recombinantly generated and loaded with antigen. In other cases, the cell surface location of ER chaperones has implications for immune responses as well as possible tumor resistance. We have produced heat-shock protein/chaperone protein-based cancer vaccines called "chaperonerich cell lysate" (CRCL) that are conglomerates of chaperones enriched from solid tumors by an isoelectric focusing technique. These preparations have been effective against numerous murine tumors, as well as in a canine with an advanced lung carcinoma treated with autologous CRCL. We also published extensive proteomic analyses of CRCL prepared from human surgically resected tumor samples. Of note, these preparations contained at least 10 ER chaperones and a number of other residents, along with many other chaperones/heatshock proteins. Gene ontology and network analyses utilizing these proteins essentially recapitulate the antigen presentation pathways and interconnections. In conjunction with our current knowledge of cell surface/extracellular ER chaperones, these data collectively suggest that a systems-level view may provide insight into the potent immune stimulatory activities of CRCL with an emphasis on the roles of ER components in those processes.
引用
收藏
页数:12
相关论文
共 164 条
[11]   Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis [J].
Bausero, MA ;
Page, DT ;
Osinaga, E ;
Asea, A .
TUMOR BIOLOGY, 2004, 25 (5-6) :243-251
[12]   Engineering secretable forms of chaperones for immune modulation and vaccine development [J].
Beachy, S. H. ;
Kisalus, A. J. ;
Repasky, E. A. ;
Subjeck, J. R. ;
Wang, X. Y. ;
Kazim, A. L. .
METHODS, 2007, 43 (03) :184-193
[13]   Pathways of Antigen Processing [J].
Blum, Janice S. ;
Wearsch, Pamela A. ;
Cresswell, Peter .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31, 2013, 31 :443-473
[14]  
Botzler C, 1998, CELL STRESS CHAPERON, V3, P6, DOI 10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO
[15]  
2
[16]   A Role for Lipid Bodies in the Cross-presentation of Phagocytosed Antigens by MHC Class I in Dendritic Cells [J].
Bougneres, Laurence ;
Helft, Julie ;
Tiwari, Sangeeta ;
Vargas, Pablo ;
Chang, Benny Hung-Junn ;
Chan, Lawrence ;
Campisi, Laura ;
Lauvau, Gregoire ;
Hugues, Stephanie ;
Kumar, Pradeep ;
Kamphorst, Alice O. ;
Dumenil, Ana-Maria Lennon ;
Nussenzweig, Michel ;
MacMicking, John D. ;
Amigorena, Sebastian ;
Guermonprez, Pierre .
IMMUNITY, 2009, 31 (02) :232-244
[17]   Protein Folding in the Endoplasmic Reticulum [J].
Braakman, Ineke ;
Hebert, Daniel N. .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2013, 5 (05)
[18]   Protein Folding and Modification in the Mammalian Endoplasmic Reticulum [J].
Braakman, Ineke ;
Bulleid, Neil J. .
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80, 2011, 80 :71-99
[19]   THE 2-SIGNAL MODEL OF LYMPHOCYTE-ACTIVATION 21 YEARS LATER [J].
BRETSCHER, P .
IMMUNOLOGY TODAY, 1992, 13 (02) :74-76
[20]  
Brichory F, 2001, CANCER RES, V61, P7908